SEC Form 4 · accession 0001395064-26-000260
TAKEDA PHARMACEUTICAL CO LTD · TAK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Milano Furuta
Officer — Chief Financial Officer · Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 6:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001395064
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 1, 2026 | A | 12,300 | $0.00 | A | 70,200 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax Obligation AwardF2,F3 | — | Jul 10, 2026 | D | 16,619 | D | Jun 1, 2026 | Jun 1, 2026 | Ordinary Shares | 16,619 | 0 | D |
| Tax Obligation AwardF4 | — | Jul 1, 2026 | A | 4,288 | A | Jun 1, 2027 | Jun 1, 2027 | Ordinary Shares | 4,288 | 11,741 | D |
| Tax Obligation AwardF4 | — | Jul 1, 2026 | A | 4,288 | A | Jun 1, 2028 | Jun 1, 2028 | Ordinary Shares | 4,288 | 8,482 | D |
| Tax Obligation AwardF4 | — | Jul 1, 2026 | A | 4,288 | A | Jun 1, 2029 | Jun 1, 2029 | Ordinary Shares | 4,288 | 4,288 | D |
Explanation of responses
- F1Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027.
- F2Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10.
- F3The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,882 to JPY 5,050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.